KORU Medical Systems (KRMD) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

KRMD Stock Forecast

KORU Medical Systems stock forecast is as follows: an average price target of $3.25 (represents a 3.17% upside from KRMD’s last price of $3.15) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

KRMD Price Target

The average price target for KORU Medical Systems (KRMD) is $3.25 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $3.50 to $3.00. This represents a potential 3.17% upside from KRMD's last price of $3.15.

KRMD Analyst Ratings

Buy

According to 3 Wall Street analysts, KORU Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for KRMD stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

KORU Medical Systems Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 14, 2024	Matthew O\'Brien	Piper Sandler	$3.50	$3.10	13.09%	11.11%
Jul 02, 2024	Kyle Rose	Canaccord Genuity	$3.00	$2.25	33.33%	-4.76%
Jan 06, 2023	-	Piper Sandler	$4.50	$3.70	21.62%	42.86%
May 05, 2022	Jason Bednar	Piper Sandler	$3.00	$2.80	7.14%	-4.76%

Row per page

Go to

The latest KORU Medical Systems stock forecast, released on Nov 14, 2024 by Matthew O\'Brien from Piper Sandler, set a price target of $3.50, which represents a 13.09% increase from the stock price at the time of the forecast ($3.10), and a 11.11% increase from KRMD last price ($3.15).

KORU Medical Systems Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	2
Avg Price Target	$3.50	$3.50	$3.25
Last Closing Price	$3.15	$3.15	$3.15
Upside/Downside	11.11%	11.11%	3.17%

In the current month, the average price target of KORU Medical Systems stock is $3.50, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 11.11% increase as opposed to KORU Medical Systems's last price of $3.15. This month's average price target is down 0.00% compared to last quarter, and up 7.69% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 08, 2024	Piper Sandler	Neutral	Neutral	Hold
Aug 08, 2024	Piper Sandler	Overweight	Overweight	Hold
Jul 02, 2024	Canaccord Genuity	Buy	Buy	Hold
Sep 07, 2023	B. Riley	-	Buy	Initialise
Nov 10, 2022	Piper Sandler	-	Overweight	Upgrade
Nov 10, 2022	Canaccord Genuity	-	Buy	Upgrade

Row per page

Go to

KORU Medical Systems's last stock rating was published by Piper Sandler on Aug 08, 2024. The company gave KRMD a "Neutral" rating, the same as its previous rate.

KORU Medical Systems Financial Forecast

KORU Medical Systems Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$7.00M	$6.94M	$7.39M	$7.34M	$7.76M	$6.55M	$6.24M	$6.49M	$6.04M	$5.53M	$5.43M	$4.06M	$6.08M	$7.71M	$6.33M	$6.22M	$6.62M
Avg Forecast	$11.82M	$11.15M	$10.72M	$10.07M	$10.38M	$9.66M	$9.34M	$8.78M	$8.13M	$7.67M	$7.57M	$7.48M	$6.94M	$7.93M	$6.90M	$7.44M	$7.38M	$6.78M	$6.29M	$6.06M	$6.06M	$5.42M	$5.20M	$5.10M	$4.69M	$7.11M	$6.53M	$6.20M	$5.36M	$5.48M
High Forecast	$12.10M	$11.42M	$10.98M	$10.32M	$10.63M	$9.89M	$9.57M	$8.96M	$8.25M	$7.68M	$7.57M	$7.66M	$7.11M	$7.93M	$7.07M	$7.62M	$7.56M	$6.78M	$6.29M	$6.06M	$6.06M	$5.42M	$5.20M	$5.10M	$4.69M	$7.11M	$6.53M	$6.20M	$5.36M	$5.48M
Low Forecast	$11.57M	$10.91M	$10.50M	$9.86M	$10.16M	$9.45M	$9.15M	$8.59M	$8.01M	$7.67M	$7.57M	$7.32M	$6.93M	$7.93M	$6.76M	$7.28M	$7.23M	$6.78M	$6.29M	$6.06M	$6.06M	$5.42M	$5.20M	$5.10M	$4.69M	$7.11M	$6.53M	$6.20M	$5.36M	$5.48M
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.88%	1.01%	0.99%	1.00%	1.14%	1.04%	1.03%	1.07%	1.11%	1.06%	1.06%	0.87%	0.86%	1.18%	1.02%	1.16%	1.21%

KORU Medical Systems's average Quarter revenue forecast for Dec 23 based on 3 analysts is $6.94M, with a low forecast of $6.93M, and a high forecast of $7.11M. KRMD's average Quarter revenue forecast represents a -0.84% decrease compared to the company's last Quarter revenue of $7.00M (Sep 23).

KORU Medical Systems EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-1.56M	$-2.88M	$-2.79M	$-2.32M	$-1.36M	$-3.47M	$-3.01M	$-1.99M	$-1.20M	$-1.26M	$-2.08M	$-1.06M	$451.77K	$3.76M	$878.86K	$1.80M	$2.64M
Avg Forecast	$-1.70M	$-1.61M	$-1.54M	$-1.45M	$-1.50M	$-1.39M	$-1.35M	$-1.26M	$-1.17M	$-1.11M	$-1.09M	$-4.84M	$-1.00M	$-1.14M	$-994.27K	$-3.83M	$-108.66K	$-639.21K	$-592.43K	$-3.03M	$-571.51K	$-511.19K	$-490.43K	$-2.10M	$-441.71K	$-669.99K	$-615.74K	$678.58K	$-505.39K	$-516.28K
High Forecast	$-1.67M	$-1.57M	$-1.51M	$-1.42M	$-1.46M	$-1.36M	$-1.32M	$-1.24M	$-1.15M	$-1.11M	$-1.09M	$-3.88M	$-999.21K	$-1.14M	$-973.39K	$-3.06M	$-86.93K	$-639.21K	$-592.43K	$-2.42M	$-571.51K	$-511.19K	$-490.43K	$-1.68M	$-441.71K	$-669.99K	$-615.74K	$814.30K	$-505.39K	$-516.28K
Low Forecast	$-1.74M	$-1.65M	$-1.58M	$-1.49M	$-1.53M	$-1.43M	$-1.38M	$-1.29M	$-1.19M	$-1.11M	$-1.09M	$-5.81M	$-1.03M	$-1.14M	$-1.02M	$-4.60M	$-130.39K	$-639.21K	$-592.43K	$-3.63M	$-571.51K	$-511.19K	$-490.43K	$-2.52M	$-441.71K	$-669.99K	$-615.74K	$542.86K	$-505.39K	$-516.28K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.37%	2.90%	0.73%	21.38%	2.12%	5.85%	0.99%	3.49%	2.35%	2.58%	0.99%	2.39%	-0.67%	-6.11%	1.30%	-3.55%	-5.12%

1 analysts predict KRMD's average Quarter EBITDA for Dec 20 to be $-441.71K, with a high of $-441.71K and a low of $-441.71K. This is -197.77% lower than KORU Medical Systems's previous annual EBITDA (Sep 20) of $451.77K.

KORU Medical Systems Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-1.37M	$-2.50M	$-2.41M	$-1.98M	$-1.23M	$-2.92M	$-2.54M	$-1.07M	$-1.09M	$-1.12M	$-1.28M	$-834.63K	$249.18K	$-1.08M	$449.43K	$-80.26K	$651.81K
Avg Forecast	$98.90K	$-457.78K	$-514.03K	$-948.89K	$-641.91K	$-917.02K	$-1.01M	$-1.28M	$-1.42M	$-1.79M	$-1.97M	$-4.06M	$-1.83M	$-2.29M	$-2.60M	$-3.21M	$-175.05K	$-2.48M	$-2.92M	$-2.54M	$-1.55M	$-1.12M	$-916.23K	$-1.28M	$-260.85K	$899.28K	$916.23K	$449.43K	$458.11K	$229.06K
High Forecast	$102.03K	$-445.28K	$-500.00K	$-922.98K	$-624.39K	$-891.98K	$-981.18K	$-1.25M	$-1.24M	$-1.74M	$-1.92M	$-3.25M	$-1.38M	$-2.23M	$-2.53M	$-2.57M	$-140.04K	$-2.48M	$-2.92M	$-2.03M	$-1.55M	$-1.12M	$-916.23K	$-1.02M	$-260.85K	$899.28K	$916.23K	$539.31K	$458.11K	$229.06K
Low Forecast	$96.20K	$-472.27K	$-530.31K	$-978.94K	$-662.24K	$-946.06K	$-1.04M	$-1.32M	$-1.61M	$-1.84M	$-2.03M	$-4.87M	$-2.29M	$-2.37M	$-2.68M	$-3.85M	$-210.06K	$-2.48M	$-2.92M	$-3.05M	$-1.55M	$-1.12M	$-916.23K	$-1.53M	$-260.85K	$899.28K	$916.23K	$359.54K	$458.11K	$229.06K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.60%	0.96%	0.75%	11.29%	0.49%	1.00%	1.00%	0.69%	0.98%	1.23%	1.00%	3.20%	0.28%	-1.17%	1.00%	-0.18%	2.85%

KORU Medical Systems's average Quarter net income forecast for Dec 20 is $-260.85K, with a range of $-260.85K to $-260.85K. KRMD's average Quarter net income forecast represents a -204.69% decrease compared to the company's last Quarter net income of $249.18K (Sep 20).

KORU Medical Systems SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.62M	$5.30M	$5.43M	$4.76M	$4.83M	$5.53M	$5.49M	$4.88M	$3.90M	$4.09M	$4.99M	$2.99M	$3.08M	$3.20M	$2.76M	$2.80M	$2.44M
Avg Forecast	$7.40M	$6.98M	$6.72M	$6.31M	$6.50M	$6.05M	$5.85M	$5.50M	$5.09M	$4.81M	$4.74M	$4.69M	$4.35M	$4.97M	$4.32M	$6.95M	$6.29M	$4.25M	$3.94M	$5.49M	$3.80M	$3.40M	$3.26M	$4.99M	$2.94M	$4.45M	$4.09M	$2.85M	$3.36M	$3.43M
High Forecast	$7.58M	$7.15M	$6.88M	$6.46M	$6.66M	$6.20M	$6.00M	$5.61M	$5.17M	$4.81M	$4.74M	$4.80M	$4.46M	$4.97M	$4.43M	$8.34M	$7.55M	$4.25M	$3.94M	$6.59M	$3.80M	$3.40M	$3.26M	$5.99M	$2.94M	$4.45M	$4.09M	$3.42M	$3.36M	$3.43M
Low Forecast	$7.25M	$6.84M	$6.58M	$6.18M	$6.36M	$5.92M	$5.73M	$5.38M	$5.02M	$4.80M	$4.74M	$4.59M	$4.34M	$4.97M	$4.23M	$5.56M	$5.03M	$4.25M	$3.94M	$4.39M	$3.80M	$3.40M	$3.26M	$3.99M	$2.94M	$4.45M	$4.09M	$2.28M	$3.36M	$3.43M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.93%	1.23%	0.78%	0.76%	1.14%	1.40%	1.00%	1.28%	1.15%	1.25%	1.00%	1.02%	0.69%	0.78%	0.97%	0.83%	0.71%

KORU Medical Systems's average Quarter SG&A projection for Dec 23 is $4.35M, based on 3 Wall Street analysts, with a range of $4.34M to $4.46M. The forecast indicates a -5.91% fall compared to KRMD last annual SG&A of $4.62M (Sep 23).

KORU Medical Systems EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.03	$-0.05	$-0.05	$-0.04	$-0.03	$-0.07	$-0.06	$-0.02	$-0.02	$-0.03	$-0.03	$-0.02	$0.01	$-0.03	$0.01	$-0.00	$0.02
Avg Forecast	-	$-0.01	$-0.01	$-0.02	$-0.01	$-0.02	$-0.02	$-0.03	$-0.03	$-0.04	$-0.04	$-0.04	$-0.04	$-0.05	$-0.06	$-0.05	$-0.06	$-0.05	$-0.06	$-0.06	$-0.03	$-0.02	$-0.02	$-0.01	$-0.01	$0.02	$0.02	$0.02	$0.01	$0.01
High Forecast	-	$-0.01	$-0.01	$-0.02	$-0.01	$-0.02	$-0.02	$-0.03	$-0.03	$-0.04	$-0.04	$-0.04	$-0.03	$-0.05	$-0.06	$-0.05	$-0.06	$-0.05	$-0.06	$-0.06	$-0.03	$-0.02	$-0.02	$-0.01	$-0.01	$0.02	$0.02	$0.02	$0.01	$0.01
Low Forecast	-	$-0.01	$-0.01	$-0.02	$-0.01	$-0.02	$-0.02	$-0.03	$-0.04	$-0.04	$-0.04	$-0.04	$-0.05	$-0.05	$-0.06	$-0.05	$-0.06	$-0.05	$-0.06	$-0.06	$-0.03	$-0.02	$-0.02	$-0.01	$-0.01	$0.02	$0.02	$0.02	$0.01	$0.01
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.60%	0.97%	1.06%	0.77%	0.50%	1.02%	1.00%	0.71%	1.01%	1.26%	4.35%	3.35%	0.51%	-1.33%	0.50%	-0.20%	3.30%

According to 1 Wall Street analysts, KORU Medical Systems's projected average Quarter EPS for Dec 20 is $-0.01, with a low estimate of $-0.01 and a high estimate of $-0.01. This represents a -156.94% decrease compared to KRMD previous annual EPS of $0.01 (Sep 20).

KORU Medical Systems Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ATRC	AtriCure	$34.72	$49.57	42.77%	Buy
KRMD	KORU Medical Systems	$3.15	$3.25	3.17%	Buy
MMSI	Merit Medical Systems	$103.94	$100.78	-3.04%	Buy
LMAT	LeMaitre Vascular	$103.55	$85.25	-17.67%	Buy

KRMD Forecast FAQ

Is KORU Medical Systems a good buy?

Yes, according to 3 Wall Street analysts, KORU Medical Systems (KRMD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of KRMD's total ratings.

What is KRMD's price target?

KORU Medical Systems (KRMD) average price target is $3.25 with a range of $3 to $3.5, implying a 3.17% from its last price of $3.15. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will KORU Medical Systems stock go up soon?

According to Wall Street analysts' prediction for KRMD stock, the company can go up by 3.17% (from the last price of $3.15 to the average price target of $3.25), up by 11.11% based on the highest stock price target, and down by -4.76% based on the lowest stock price target.

Can KORU Medical Systems stock reach $5?

KRMD's average twelve months analyst stock price target of $3.25 does not support the claim that KORU Medical Systems can reach $5 in the near future.

What is KORU Medical Systems's current price target trend?

1 Wall Street analyst forecast a $3.5 price target for KORU Medical Systems (KRMD) this month, up 11.11% from its last price of $3.15. Compared to the last 3 and 12 months, the average price target increased by 11.11% and increased by 3.17%, respectively.

What are KORU Medical Systems's analysts' financial forecasts?

KORU Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $38.15M (high $39.05M, low $37.35M), average EBITDA is $-5.497M (high $-5.382M, low $-5.627M), average net income is $-3.851M (high $-3.746M, low $-3.973M), average SG&A $23.9M (high $24.47M, low $23.4M), and average EPS is $-0.084 (high $-0.0817, low $-0.0867). KRMD's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $43.76M (high $44.82M, low $42.84M), average EBITDA is $-6.305M (high $-6.173M, low $-6.459M), average net income is $-1.822M (high $-1.766M, low $-1.885M), average SG&A $27.41M (high $28.08M, low $26.84M), and average EPS is $-0.0397 (high $-0.0385, low $-0.0411).

Did the KRMD's actual financial results beat the analysts' financial forecasts?

Based on KORU Medical Systems's last annual report (Dec 2022), the company's revenue was $27.9M, beating the average analysts forecast of $26.51M by 5.24%. Apple's EBITDA was $-10.154M, beating the average prediction of $-4.368M by 132.48%. The company's net income was $-8.661M, beating the average estimation of $-8.116M by 6.72%. Apple's SG&A was $20.61M, beating the average forecast of $19.97M by 3.21%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-0.231 by -17.90%. In terms of the last quarterly report (Sep 2023), KORU Medical Systems's revenue was $7M, missing the average analysts' forecast of $7.93M by -11.68%. The company's EBITDA was $-1.562M, beating the average prediction of $-1.143M by 36.71%. KORU Medical Systems's net income was $-1.368M, missing the average estimation of $-2.293M by -40.32%. The company's SG&A was $4.62M, missing the average forecast of $4.97M by -6.93%. Lastly, the company's EPS was $-0.03, missing the average prediction of $-0.05 by -40.00%